These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7108595)
21. [Effect of perfluorochemicals on tissue PO2 levels in a subcutaneous 9L rat glioma model]. Kokunai T; Korosue K; Kuwamura K; Tamaki N; Matsumoto S Gan To Kagaku Ryoho; 1984 Oct; 11(10):2207-11. PubMed ID: 6486835 [TBL] [Abstract][Full Text] [Related]
22. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma. Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184 [TBL] [Abstract][Full Text] [Related]
23. Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. Zhang RX; Dougherty DV; Rosenblum ML Chin Med J (Engl); 1990 Aug; 103(8):658-65. PubMed ID: 2122945 [TBL] [Abstract][Full Text] [Related]
24. Measurement of sister chromatid exchange induction in intracerebral brain tumors as a method for evaluation of therapeutic drug combinations. Bodell WJ Anticancer Res; 2000; 20(5A):3099-103. PubMed ID: 11062728 [TBL] [Abstract][Full Text] [Related]
25. Effect of caffeine on cytotoxicity and sister chromatid exchange induction in sensitive and resistant rat brain tumor cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea. Aida T; Bodell WJ Cancer Res; 1987 Oct; 47(19):5052-8. PubMed ID: 3621190 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of continuous treatment with radiation in a rat brain-tumor model. Wheeler KT; Kaufman K J Neurosurg; 1981 Jul; 55(1):52-4. PubMed ID: 7241215 [TBL] [Abstract][Full Text] [Related]
27. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma. Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922 [TBL] [Abstract][Full Text] [Related]
28. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma. Teicher BA; Holden SA; Rose CM Int J Cancer; 1986 Aug; 38(2):285-8. PubMed ID: 3089945 [TBL] [Abstract][Full Text] [Related]
29. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Tamargo RJ; Myseros JS; Epstein JI; Yang MB; Chasin M; Brem H Cancer Res; 1993 Jan; 53(2):329-33. PubMed ID: 8417826 [TBL] [Abstract][Full Text] [Related]
30. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea. Sano Y; Hoshino T; Barker M; Deen DF Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362 [TBL] [Abstract][Full Text] [Related]
31. Combined cyclotron fast-neutron and BCNU therapy in a rat brain-tumor model. Spence AM; Geraci JP J Neurosurg; 1981 Apr; 54(4):461-7. PubMed ID: 7205347 [TBL] [Abstract][Full Text] [Related]
32. Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma. Storm PB; Renard VM; Moriarity JL; Tyler B; Wilentz RE; Brem H; Weingart JD Cancer Chemother Pharmacol; 2004 Oct; 54(4):361-7. PubMed ID: 15197484 [TBL] [Abstract][Full Text] [Related]
33. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model. Slagel DE; Feola J; Houchens DP; Ovejera AA Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979 [TBL] [Abstract][Full Text] [Related]
34. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats. Emerich DF; Winn SR; Bartus RT Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219 [TBL] [Abstract][Full Text] [Related]
35. Experimental evaluation of nonspecific immunostimulation and chemotherapy in the intracranial tumor-bearing Fisher rat. Selker R; Jones E; Winkelstein A; Landay A; Iannuzzi D; Kristofik M; Closson J Dev Biol Stand; 1977 Apr 13-15; 38():317-22. PubMed ID: 608518 [TBL] [Abstract][Full Text] [Related]
36. Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release. Buahin KG; Brem H J Neurooncol; 1995 Nov; 26(2):103-10. PubMed ID: 8787852 [TBL] [Abstract][Full Text] [Related]
37. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model. Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080 [TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells. Horvath Z; Bauer W; Hoechtl T; Saiko P; Fritzer-Szekeres M; Tihan T; Szekeres T Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1531-5. PubMed ID: 15571292 [TBL] [Abstract][Full Text] [Related]
39. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Liu HL; Hua MY; Chen PY; Chu PC; Pan CH; Yang HW; Huang CY; Wang JJ; Yen TC; Wei KC Radiology; 2010 May; 255(2):415-25. PubMed ID: 20413754 [TBL] [Abstract][Full Text] [Related]
40. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]